US Patent 7560553 Use of fuse nicotinamides to promote neurogenesis

Patent 7560553 was granted and assigned to Neuralstem, Inc. on July, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Neuralstem, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7560553

Date of Patent

July 14, 2009

Patent Application Number

12049922

Date Filed

March 17, 2008

Patent Citations Received

‌

US Patent 11993613 Thiazolo[5,4-b]pyridine MALT-1 inhibitors

Patent Primary Examiner

‌

Janet L. Andres

Patent abstract

The present invention provides a group of compounds found to increase the number of neurons derived from stem cells for use as a therapeutic agent in neurological conditions or diseases. In one embodiment of the present invention, the compounds are used to detect the mechanism by which the number of neurons is increased.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7560553 Use of fuse nicotinamides to promote neurogenesis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API